R&D
LSX2026: Endogenous tissue restoration in vascular disease –...
Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.
R&D
LSX2026: Non-opioid pain relief and pharma positivity, with ...
Mike Cooke, CEO of AmacaThera, spoke with pharmaphorum at the LSX World Congress, including about non-opioid pain relief.
Oncology
LSX2026: Addressing adult eye cancer, with Roi Raz
Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Patients
Making direct-to-patient work, with Matt Wadyka
Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing
Biotech is back, with Craig Ackerman
In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
